Filter By Category
Archives
CALOXETIC ACID
Generic Name: CALOXETIC ACID
ABSTRACT -
Caloxetic acid is an investigational small molecule under early-phase clinical evaluation for a metabolic or enzymatic disorder. Its mechanism involves modulation of specific oxidative or metabolic pathways. Detailed pharmacological characterisation is ongoing in Phase I/II studies.
DOSAGE -
Oral administration; dose escalation ongoing in Phase I studies; specific dosing regimen to be established.
SIDE EFFECTS -
- Nausea
- Fatigue
- Headache
- Gastrointestinal discomfort
- Dizziness
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require immediate medical attention.
- Skin rash
- Urticaria
- Hypersensitivity reactions
- Angioedema (rare)
DRUG INTERACTIONS-
- Metabolic interaction profile to be characterised
- Monitor with hepatically metabolised co-medications
- CYP enzyme interactions possible
PREAUTONS–
- Liver function monitoring during treatment
- Pregnancy safety not established
- Use in clinical trial setting only
- Paediatric data not available
WARNINGS –
- Investigational agent — adverse event profile fully being characterised
- Hepatotoxicity cannot be excluded until safety data mature
- Report all adverse events to trial sponsor



. Developed by